Responses
Regular and Young Investigator Award Abstracts
Clinical Trial Completed
608 Results of a phase 1 study investigating camidanlumab tesirine as monotherapy and in combination with pembrolizumab in patients with selected advanced solid tumors
Compose a Response to This Article
Other responses
No responses have been published for this article.
